References
- Rivera VM. The “CVA” controversy. (Letter) N Engl J Med 1974: 290(3): 574
- Wolf PA, Kannel WB, Verter J. Current status of risk factors for stroke. Neurol Clin 1983: 1(1): 317–43
- Caronna JJ, Levy DE. Clinical predictors of outcome in ischemic stroke. Neurol Clin 1983: 1(1): 103–17
- Astrup J, Siesjø BK, Symon L. Thresholds in cerebral ischemia—the ischemic penumbra. (Editorial) Stroke 1981: 12(6): 723–5
- Meyer JS, Charney JZ, Rivera VM, et al. Cerebral embolization: prospective clinical analysis of 42 cases. Stroke 1971: 2(6): 541–54
- Jørgensen L, Torvik A. Ischaemic cerebrovascular diseases in an autopsy series. 1. Prevalence, location and predisposing factors in verified thrombo-embolic occlusions, and their significance in the pathogenesis of cerebral infarction. J Neurol Sci 1966: 3(5): 490–509
- Meyer JS. Shinohara T, Kanda T, et al. Diaschisis resulting from acute unilateral cerebral infarction. Arch Neurol 1970: 23(3): 241–7
- Russell RW. Pathogenesis of transient ischemic attacks. Neurol Clin 1983: 1(1): 279–90
- Rivera VM, Meyer JS, Baer PE, et al. Vertebrobasilar arterial insufficiency with dementia: controlled trials of treatment with betahistine hydrochloride. J Am Geriatr Soc 1974: 22(9): 397–406
- Bounds JV, Wiebers DO, Whisnant JP, et al. Mechanisms and timing of deaths from cerebral infarction. Stroke 1981: 12(4): 474–7
- Fisher CM. Cerebral miliary aneurysms in hypertension. Am J Pathol 1972: 66(2): 313–30
- Ackerman RH. Non-invasive carotid evaluation. Stroke 1980: 11(6): 675–8
- Rivera VM. Management of cerebral herniation. (Letter) N Engl J Med 1972: 287(3): 148
- Gilroy J, Barnhart MI, Meyer JS. Treatment of acute stroke with dextran 40. JAMA 1969: 210(2): 293–8
- Meyer JS, Charney JZ, Rivera VM, et al. Treatment with glycerol of cerebral oedema due to acute cerebral infarction. Lancet 1971: 2(732): 993–7
- Faden AI, Hallenbeck JM, Brown CO. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone. Neurology (NY) 1982: 32(10): 1083–7